Crispr Therapeutics | search
Click here to view Crispr Therapeutics news from 60+ newspapers.
Bookmark or Share- Home | CRISPR TherapeuticsLearn more about our programs. We have established a diverse portfolio across a broad range of disease areas including hemoglobinopathies, oncology, diabetes and cardiovascular disease. View Pipeline.
- Who We Are | CRISPR TherapeuticsAt CRISPR Therapeutics, our aim is to find cures for people suffering from serious diseases through transformative gene-based medicines. We innovate for the sake of patients and families. Creating an impact. The first-ever CRISPR-based therapy is a direct reflection of our patient-forward philosophy.
- Therapies | CRISPR TherapeuticsTherapies | CRISPR Therapeutics. CASGEVY™. First-ever approved CRISPR-based therapy. This historic milestone validates CRISPR/Cas9 gene-editing technology as we look ahead to the future of medicine.
- CRISPR Therapeutics - WikipediaCRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases.
- The world’s first CRISPR therapy is approved: who will receive it?The UK’s regulator has approved the world’s first CRISPR–Cas9 gene editing therapy, which aims to cure sickle cell disease and transfusion-dependent β-thalassemia. Casgevy (exagamglogene...
More
